InsidersTradesSigma
Explore the complete record of transactions filed by Landis John B., Director. Officer active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 2 reports have been logged. Activity tracked since 9 February 2022. The latest transaction was disclosed on 9 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
John B. Landis serves as a Director at EyePoint Pharmaceuticals, Inc. He brings his expertise in corporate governance and strategy. His role as a director includes participating in board meetings and contributing to strategic decision-making for the company.